Brain PET in Suspected Dementia: Patterns of Altered FDG Metabolism
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
The diagnosis of dementia syndromes can be challenging for clinicians, particularly in the early stages of disease. Patients with higher education levels may experience a marked decline in cognitive function before their dementia is detectable with routine testing methods. In addition, comorbid conditions (eg, depression) and the use of certain medications can confound the clinical assessment. Clinicians require a high degree of certainty before making a diagnosis of Alzheimer disease or some other neurodegenerative disorder, since the impact on patients and their families can be devastating. Moreover, accurate diagnosis is important because emerging therapeutic regimens vary depending on the cause of the dementia. Clinically based testing is useful; however, the results usually do not enable the clinician to make a definitive diagnosis. For this reason, imaging biomarkers are playing an increasingly important role in the workup of patients with suspected dementia. Positron emission tomography with 2-[fluorine-18]fluoro-2-deoxy-D-glucose allows detection of neurodegenerative disorders earlier than is otherwise possible. Accurate interpretation of these studies requires recognition of typical metabolic patterns caused by dementias and of artifacts introduced by image processing. Although visual interpretation is a vital component of image analysis, computer-assisted diagnostic software has been shown to increase diagnostic accuracy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, sMRI and (18FDG)-PET indicate neurodegeneration or neuronal injury in the AT(N) framework with limitations in specifically diagnosing AD.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [369]
In the citing paper
“They cannot accurately differentiate AD from other neurodegenerative diseases with similar pathologies, such as frontotemporal degeneration and TDP-43 proteinopathies with medial temporal lobe atrophy.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [369]
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802
Self-citationMosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E. M., Holthoff, V., Kalbe, E., Sorbi, S., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045385 · Cited by 726
Self-citationFDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Foster, N. L., Heidebrink, J. L., Clark, C. M., Jagust, W. J., Arnold, S. E., Barbas, N. R., DeCarli, C. S., Scott Turner, R., Koeppe, R. A., Higdon, R., et al. (2007) · Brain · doi:10.1093/brain/awm177 · Cited by 608
Self-citationFocal cortical presentations of Alzheimer's disease
Alladi, S., Xuereb, J., Bak, T., Nestor, P., Knibb, J., Patterson, K., & Hodges, J. R. (2007) · Brain · doi:10.1093/brain/awm213 · Cited by 581
White matter lesions impair frontal lobe function regardless of their location
Tullberg, M., Fletcher, E., DeCarli, C., Mungas, D., Reed, B. R., Harvey, D. J., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2004) · Neurology · doi:10.1212/01.wnl.0000130530.55104.b5 · Cited by 530
Black, S., Gao, F., & Bilbao, J. (2009) · Stroke · doi:10.1161/strokeaha.108.537704 · Cited by 379
Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease
Chetelat, G., Desgranges, B., Landeau, B., Mezenge, F., Poline, J. B., de la Sayette, V., Viader, F., Eustache, F., & Baron, J.-C. (2007) · Brain · doi:10.1093/brain/awm288 · Cited by 339
What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
Jagust, W., Reed, B., Mungas, D., Ellis, W., & DeCarli, C. (2007) · Neurology · doi:10.1212/01.wnl.0000269790.05105.16 · Cited by 298
Positron emission tomography imaging in dementia
HERHOLZ, K., CARTER, S. F., & JONES, M. (2007) · The British Journal of Radiology · doi:10.1259/bjr/97295129 · Cited by 287
Research works printed but not linked: 3
- Jeong Y, 2005, J Nucl Med, 46, 233
- De Reuck J, 1997, Acta Neurol Belg, 97, 168
- Baron JC, 1982, J Nucl Med, 23, 391
Cited by
Items 201–259 of 259
Amyloidassoziierte Krankheiten des Zentralnervensystems: multimodale Befundung
Miller‐Thomas, M. M., Sipe, A. L., Benzinger, T. L. S., McConathy, J., Connolly, S., & Schwetye, K. E. (2017) · Neuroradiologie Scan · doi:10.1055/s-0043-118838 · Cited by 1
Hoch, M. J., Franceschi, A. M., & Shepherd, T. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-65106-4_123
A More Effective Method to Prevent or Control Diabetes and Alzheimer's Disease
Dyke, K. V. (2017) · Global Journal of Intellectual & Developmental Disabilities · doi:10.19080/gjidd.2017.01.555559
Neuroimaging in Clinical Geriatric Psychiatry
Burhan, A. M., Anazodo, U., & Soucy, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-67555-8_3
The role of PET/CT in the diagnostics of dementia
Mączewska, J., & Królicki, L. (2016) · Aktualności Neurologiczne · doi:10.15557/an.2016.0019
Dyke, K. V., Geldenhuys, W. J., & Robart, A. R. (2017) · International Journal of open Access Ophthalmology · doi:10.15226/2474-9249/2/2/00121
Nagaratnam, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-96998-5_10
Saeed, U. (2018) · TSpace (University of Toronto)
Balajoo, S. M., Rahmani, F., Khosrowabadi, R., Meng, C., Grimmer, T., Drzezga, A. E., Zarei, M., Sorg, C., & Tahmasian, M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/642629
Imagerie métabolique et moléculaire : l’exemple des maladies neurodégénératives
Gabelle, A. (2018) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30217-1
Nuklearnomedicinske preiskave v diagnostiki demence in parkinsonizmov
Rus, T., Jamšek, J., Berlot, R., Popovič, K. Š., Grmek, M., & Trošt, M. (2020) · Slovenian Medical Journal · doi:10.6016/zdravvestn.2935 · Cited by 1
Positron Emission Tomography (PET) in Dementias
Wu, D. (2020) · Springer eBooks · doi:10.1007/978-3-030-40893-0_1
Maurer, A. N., Sayah, A., Guzman, J. C., & Levy, A. D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316823040.030
Biomarkers of Agitation in Patients with Alzheimer's disease
Ruthirakuhan, M. T. (2019) · TSpace (University of Toronto)
Balajoo, S. M., Rahmani, F., Khosrowabadi, R., Meng, C., Eickhoff, S. B., Grimmer, T., Zarei, M., Drzezga, A. E., Sorg, C., & Tahmasian, M. (2021) · Research Square · doi:10.21203/rs.3.rs-823388/v1
Central Nervous System Molecular Imaging
Sólnes, L. B., Jacobs, A. H., Coughlin, J. M., Du, Y., Goel, R., Hammoud, D. A., & Pomper, M. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00088-0 · Cited by 1
Introduction to Molecular Neuroimaging Applications
Tong, E., & Yamin, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_6
Drake, T. C. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.214321
Formulação de guia de melhores práticas em medicina nuclear
Rigolon, M. Y. (2018) · doi:10.47749/t/unicamp.2018.1045506
Normal Brain Amyvid and FDG PET/CT scans for dementia
Peacock, J. G. (2022) · Radiopaedia.org · doi:10.53347/rid-96174
Myette‐Côté, É., Castellano, C., Fortier, M., St‐Pierre, V., & Cunnane, S. C. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197501207.003.0017
Nuclear Medicine Methods in Dementia
Budak, E. S., & Aydın, F. (2017) · Nuclear Medicine Seminars · doi:10.4274/nts.020
Franceschi, A. M., Hoch, M. J., & Shepherd, T. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-65106-4_113
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37754-6.50280-3
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-44781-2.50189-3
CPI Neuroradiology Module 2021
Buch, K. A., Bunch, P. M., Chiang, G. C.-Y., Kennedy, T. A., Lee-Diaz, J. A., Noujaim, D. L., Noujaim, S. E., Shah, V. N., & Small, J. E. (2021) · doi:10.54057/cpi.nu2021
CPI Nuclear Radiology Module 2019
Akin, E. A., Green, E. D., Hutchins, E. B., Kuo, P. H., Reynolds, S., Servaes, S. E., Siegel, A. H., Yen, S. P. F., & Yoo, D. C. (2019) · doi:10.54057/cpi.nuc2019
Eshuis, S. A. (2023) · Medische beeldvorming en radiotherapie · doi:10.1007/978-90-368-2819-2_15
Leporace, M., Calabria, F. F., Gaudio, E., Schillaci, O., Ciaccio, A., & Bagnato, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90454-4.00006-9
Synaptic PET Imaging in Neurodegeneration
Chen, M., Matuskey, D., Finnema, S. J., & Carson, R. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-35098-6_10 · Cited by 1
Case-Based Guide for Image Interpretation and Reporting
Mosci, K., Thientunyakit, T., Cross, D. J., Bischof, G. N., Arbizu, J., & Minoshima, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-35098-6_17
Self-citationHo, M., Sharma, R., & Lazic, S. (2009) · Radiopaedia.org · doi:10.53347/rid-7270
Evaluating Explanations of an Alzheimer’s Disease 18F-FDG Brain PET Black-Box Classifier
Santi, L. A. D., Bargagna, F., Santarelli, M. F., & Positano, V. (2023) · Communications in computer and information science · doi:10.1007/978-3-031-44064-9_30
Simulation of a semiconductor voxelized helmet brain PET scanner
Kolstein, M., Chmeissani, M., Saini, D., & Miramón, J. C. M. (2024) · Journal of Instrumentation · doi:10.1088/1748-0221/19/04/p04030
Shin, S., Seok, J. W., Keun-young Kim, A., Kim, J., Nam, H., & Pak, K. (2024) · medRxiv · doi:10.1101/2024.04.29.24306506
Decker, J. H., Wintermark, M., & Zeineh, M. (2024) · What radiology residents need to know · doi:10.1007/978-3-031-55124-6_17
Anatomical Organization of central nervous system (CNS)
Ortiz, G. J., Martinez-Menendez, C., Harris, K., Hinojosa, M., & Schulz, P. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19130-5.00001-0
A Res_shift Module Based Architecture for The Diagnosis of Alzheimer's Disease
Wang, Y., Tian, X., Lin, Y., Han, D., Ge, H., & Zhao, J. (2024) · International Conference on Biomedical Imaging, Signal Processing (ICBSP) · doi:10.1145/3707172.3707188
Functional Neuroimaging in Nuclear Medicine
Dizdar, N. A., & Cayir, D. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009689 · Cited by 1
Interhemispheric cortical thickness asymmetry is an imaging biomarker of dementia type
Oliveira, F. P. M., Constantino, C. S., & Costa, D. C. (2025) · European Radiology · doi:10.1007/s00330-025-11535-y
18F-FDG PET for Neurodegenerative Diseases: Principles and Progress
Thientunyakit, T., Wannasoupol, N., Sethanandha, C., Piyapittayanan, S., Siriprapa, T., Thongpraparn, T., Muangpaisan, W., & Gelovani, J. G. (2025) · Neuromethods · doi:10.1007/978-1-0716-4494-2_6
Central Nervous System Nuclear Imaging
Muhleman, M., Brown, R. K. J., Wong, K. K., Al-Dulaimi, R., & Bohnen, N. I. (2025) · Seminars in Roentgenology · doi:10.1053/j.ro.2025.04.006
Self-citationFDG PET of the brain to screen for neurodegenerative disease in older liver transplant candidates
Jones, N. B., Schwartz, T. M., Bishay, S., Robb, W. H., Sams, A., Kogan, J., Nable, M., Nelson, S., Zhao, O. S., Hohman, T. J., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07382-0
CPI Neuroradiology Module 2025
Borja, M. J., Dahmoush, H., Gadde, J. A., Goldman-Yassen, A. E., Iv, M., Peterson, R. B., Sawatzky, B. D., Seifert, K. D., Talbott, J. F., & Villanueva-Meyer, J. R. (2025) · doi:10.54057/cpi.nu2025
Soleimani‐Meigooni, D. N., & Rabinovici, G. D. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.006
Radford‐Smith, D. E., Rooney, C. H. E., McGing, J., Shinozaki, A., Deen, S. S., Zaccagna, F., Healicon, R., Ball, V., Anthony, D. C., Tyler, D. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.17.695057
Kim, S., Lee, P., Oh, K. T., Byun, M. S., Yi, D., Lee, J. H., Kim, Y. K., Ye, B. S., Yun, M. J., Lee, D. Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14767314
Neurological Evaluation of Violent Offenders
Bertelson, J. A. (2026) · Wiley eBooks · doi:10.1002/9781118832202.ch36
Pan, X. (2019) · theses.fr (ABES) · doi:10.70675/8003ded2za2acz4f90zbe77z2fcb036f6a84 · Cited by 1
[18F]-Flortaucipir PET/MRI Supports a 4R Tauopathy Phenotype in Corticobasal Degeneration
Chen, M., & Franceschi, A. M. (2026) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000006461
Metabolic neural networks of the marmoset brain in awake and isoflurane-anesthetized resting states
Koo, D., Cho, A.-S., Kim, J. W., Lee, H.-S., Kang, B.-C., Lee, J. Y., & Lee, H.-Y. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.05.003
Yue, Y., Yu, W., Jiang, D., Tian, Y., Wang, C., Sun, F., Shao, S., Wan, P., & Wang, Y. (2026) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000002185
Tang, C., Tang, A., Wan, M., Li, C., Ruan, W., Liu, F. M., Fang, H., Gai, Y., Jiang, D., Zhou, W., et al. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.122039 · Cited by 1
Decoding disease progression: Biomarker in Alzheimer’s and Parkinson’s disease
Paul, S., Rai, S., & Kumar, S. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.04.001
Effect of metformin treatment on brain 18F-FDG uptake: a translational study
de la Rosa, R. F., Domingo, G. C., Nespral, P., Marcos-Macías, E., Vaillant, M., García‐García, L., Pozo, M. A., Matías‐Guiu, J. A., Cabrera‐Martín, M. N., Brackhan, M., et al. (2026) · Frontiers in Radiology · doi:10.3389/fradi.2026.1917175 · Cited by 1
Perovnik, M., & Kolmančič, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34176-2.00013-4
Poonam, Rana, R., Thakur, M., Sharma, A., Pannu, S., Sharma, S., Naman, S., Rani, S., Devi, D., Kumar, V., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1908830
PET for Evaluation of Neurologic Diseases
Veziroglu, E., Nikpanah, M., Farhadi, F., Kalbi, D., Hensley, C., & McConathy, J. (2026) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2026.07.008
Metadata
- Authors
- Brown, R. K. J., Bohnen, N. I., Wong, K. K., Minoshima, S., & Frey, K. A.
- Affiliations
- University of Washington (US)
- University of Michigan (US)
- Venue
- RadioGraphics
- Published
- 2014-05
- Volume
- 34
- Issue
- 3
- Pages
- 684-701
- ISSN
- 0271-5333 (ISSN-L)
- 1527-1323
- OpenAlex
- W2141562510
- Cited by
- 256
- References
- 76
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 24 · 2023: 22 · 2022: 30 · 2021: 27 · 2020: 28 · 2019: 22 · 2018: 24 · 2017: 20 · 2016: 18 · 2015: 7 · 2014: 1
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Radiographics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- dementia, FDG-PET, FDG metabolism, Alzheimer's disease, neurodegenerative diseases, imaging biomarkers, early diagnosis, image artifacts, computer-aided diagnosis, visual interpretation, comorbid depression
- MeSH terms
- Brain, Dementia, Diagnosis, Differential, Humans, Image Processing, Computer-Assisted, Tissue Distribution, Artifacts, Radiopharmaceuticals, Neurodegenerative Diseases, Fluorodeoxyglucose F18, Early Diagnosis, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.